abrdn Healthcare Opportunities Fund
About this Fund
The abrdn Healthcare Opportunities Fund is a leading mutual fund company specializing in providing investors with a diverse range of investment opportunities across the healthcare sector. As a prominent player in the asset management industry, abrdn offers a comprehensive portfolio of mutual funds that cater to various investor preferences, including equity, debt, and hybrid funds. By focusing on the rapidly evolving healthcare landscape, the company enables investors to capitalize on the growth potential of this critical sector, which is driven by an aging population, advancements in medical technology, and an increasing demand for healthcare services. With a strong emphasis on wealth management, abrdn's investment approach is centered on delivering long-term value to its investors, who can benefit from the company's extensive expertise in navigating the complexities of the healthcare market. The abrdn Healthcare Opportunities Fund is designed to provide investors with a strategic investment vehicle that leverages the company's in-depth knowledge of the healthcare industry, allowing them to make informed investment decisions. By investing in a diversified portfolio of healthcare-related stocks, bonds, and other securities, investors can mitigate risk while tapping into the sector's growth potential. The company's investment strategy is built around a rigorous research process, which involves identifying high-quality investment opportunities and conducting thorough due diligence to ensure that investors' interests are protected. abrdn's commitment to transparency, accountability, and investor-centricity has earned the trust of its clients, who appreciate the company's dedication to providing tailored investment solutions that meet their unique needs and goals. Whether investors are seeking to grow their wealth over the long term or generate regular income through systematic investment plans (SIPs), the abrdn Healthcare Opportunities Fund offers a flexible and reliable investment platform that aligns with their objectives. With a proven track record of delivering strong investment performance, the abrdn Healthcare Opportunities Fund has established itself as a trusted partner for investors seeking to capitalize on the healthcare sector's growth potential. By combining its deep understanding of the healthcare industry with a disciplined investment approach, abrdn has built a reputation for excellence in asset management, which is reflected in its ability to attract and retain a loyal client base. As a specialist in mutual fund management, the company continues to innovate and expand its product offerings, ensuring that investors have access to a broad range of investment opportunities that cater to their evolving needs and risk profiles. By focusing on the healthcare sector, abrdn is well-positioned to capitalize on the sector's long-term growth potential, driven by demographic trends, technological advancements, and an increasing focus on healthcare as a critical component of economic development. As a result, investors can trust the abrdn Healthcare Opportunities Fund to provide them with a reliable and effective investment platform that supports their wealth management goals and aspirations.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
6.29%
|
$49.75 | 397,060 |
| 2 | ABT ABBOTT LABORATORIES Since 2026-05-10 | 002824BG4 | Debt |
1.34%
|
$10.56 | 10,498,000 |
| 3 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
7.22%
|
$57.11 | 249,937 |
| 4 | ABBV ABBVIE INC Since 2026-05-10 | 00287YAW9 | Debt |
0.34%
|
$2.68 | 3,080,000 |
| 5 | ABBV ABBVIE INC Since 2026-05-10 | 00287YAY5 | Debt |
0.41%
|
$3.24 | 3,245,000 |
| 6 | ABBV ABBVIE INC Since 2026-05-10 | 00287YBF5 | Debt |
0.68%
|
$5.36 | 5,303,000 |
| 7 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
0.66%
|
$5.21 | 15,909 |
| 8 | AMGN AMGEN INC Since 2026-05-10 | 031162CQ1 | Debt |
0.27%
|
$2.17 | 2,200,000 |
| 9 | AMGN AMGEN INC Since 2026-05-10 | 031162CZ1 | Debt |
0.31%
|
$2.44 | 2,795,000 |
| 10 | RCUS Arcus Biosciences Inc Since 2026-05-10 | 03969F109 | Equity (Common) |
0.38%
|
$3.01 | 126,168 |
| 11 | AZN ASTRAZENECA PLC Since 2026-05-10 | 046353AD0 | Debt |
0.68%
|
$5.41 | 4,750,000 |
| 12 | BCRX BioCryst Pharmaceuticals Inc Since 2026-05-10 | 09058V103 | Equity (Common) |
0.33%
|
$2.60 | 333,618 |
| 13 | CDNA CareDx Inc Since 2026-05-10 | 14167L103 | Equity (Common) |
0.50%
|
$3.98 | 211,434 |
| 14 | CRL Charles River Laboratories International Inc Since 2026-05-10 | 159864107 | Equity (Common) |
0.83%
|
$6.58 | 32,984 |
| 15 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.96%
|
$7.60 | 114,502 |
| 16 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.67%
|
$5.31 | 66,869 |
| 17 | DHC Diversified Healthcare Trust Since 2026-05-10 | 25525P107 | Equity (Common) |
0.18%
|
$1.43 | 293,879 |
| 18 | GILD GILEAD SCIENCES INC Since 2026-05-10 | 375558BM4 | Debt |
1.25%
|
$9.90 | 10,000,000 |
| 19 | DOC Healthpeak Properties Inc Since 2026-05-10 | 42250P103 | Equity (Common) |
1.26%
|
$9.98 | 620,394 |
| 20 | HUM Humana Inc Since 2026-05-10 | 444859102 | Equity (Common) |
2.76%
|
$21.86 | 85,345 |
| 21 | INSP Inspire Medical Systems Inc Since 2026-05-10 | 457730109 | Equity (Common) |
2.25%
|
$17.81 | 193,095 |
| 22 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
4.03%
|
$31.86 | 56,256 |
| 23 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.56%
|
$4.45 | 19,723 |
| 24 | LTC LTC Properties Inc Since 2026-05-10 | 502175102 | Equity (Common) |
0.73%
|
$5.74 | 166,842 |
| 25 | LUCD Lucid Diagnostics Inc Since 2026-05-10 | 54948X109 | Equity (Common) |
0.48%
|
$3.77 | 3,457,894 |
| 26 | MPT Medical Properties Trust Inc Since 2026-05-10 | 58463J304 | Equity (Common) |
0.17%
|
$1.33 | 266,557 |
| 27 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
6.11%
|
$48.33 | 459,113 |
| 28 | MRK MERCK & CO INC Since 2026-05-10 | 58933YAX3 | Debt |
0.50%
|
$3.94 | 4,000,000 |
| 29 | MOH Molina Healthcare Inc Since 2026-05-10 | 60855R100 | Equity (Common) |
1.56%
|
$12.33 | 71,056 |
| 30 | MYGN Myriad Genetics Inc Since 2026-05-10 | 62855J104 | Equity (Common) |
0.69%
|
$5.45 | 885,801 |
| 31 | NHI National Health Investors Inc Since 2026-05-10 | 63633D104 | Equity (Common) |
0.05%
|
$0.43 | 5,596 |
| 32 | NEO NeoGenomics Inc Since 2026-05-10 | 64049M209 | Equity (Common) |
1.51%
|
$11.96 | 1,017,151 |
| 33 | OHI Omega Healthcare Investors Inc Since 2026-05-10 | 681936100 | Equity (Common) |
1.67%
|
$13.21 | 297,889 |
| 34 | PFE PFIZER INC Since 2026-05-10 | 717081EC3 | Debt |
0.38%
|
$3.00 | 3,200,000 |
| 35 | PFE PFIZER INC Since 2026-05-10 | 717081ET6 | Debt |
1.01%
|
$8.01 | 8,100,000 |
| 36 | PRAX Praxis Precision Medicines Inc Since 2026-05-10 | 74006W207 | Equity (Common) |
1.38%
|
$10.94 | 37,107 |
| 37 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
1.49%
|
$11.78 | 15,260 |
| 38 | SBRA Sabra Health Care REIT Inc Since 2026-05-10 | 78573L106 | Equity (Common) |
1.50%
|
$11.87 | 626,862 |
| 39 | SRPT Sarepta Therapeutics Inc Since 2026-05-10 | 803607100 | Equity (Common) |
2.43%
|
$19.23 | 893,720 |
| 40 | SERA Sera Prognostics Inc Since 2026-05-10 | 81749D107 | Equity (Common) |
0.42%
|
$3.35 | 1,133,977 |
| 41 | SPRY ARS Pharmaceuticals Inc Since 2026-05-10 | 82835W108 | Equity (Common) |
2.09%
|
$16.52 | 1,417,732 |
| 42 | TNDM Tandem Diabetes Care Inc Since 2026-05-10 | 875372203 | Equity (Common) |
0.72%
|
$5.69 | 258,774 |
| 43 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
3.61%
|
$28.52 | 49,225 |
| 44 | TMO THERMO FISHER SCIENTIFIC Since 2026-05-10 | 883556CY6 | Debt |
0.83%
|
$6.54 | 6,500,000 |
| 45 | VTR Ventas Inc Since 2026-05-10 | 92276F100 | Equity (Common) |
1.19%
|
$9.39 | 121,336 |
| 46 | WELL Welltower Inc Since 2026-05-10 | 95040Q104 | Equity (Common) |
1.36%
|
$10.75 | 57,915 |
| 47 | ZBH ZIMMER BIOMET HOLDINGS Since 2026-05-10 | 98956PAG7 | Debt |
0.71%
|
$5.58 | 6,000,000 |
| 48 | ZTS Zoetis Inc Since 2026-05-10 | 98978V103 | Equity (Common) |
2.82%
|
$22.28 | 177,071 |
| 49 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
4.27%
|
$33.74 | 351,290 |
| 50 | PCSC Perceptive Capital Solutions Corp Since 2026-05-10 | — | Equity (Common) |
0.35%
|
$2.77 | 212,600 |
| 51 | OCS Oculis Holding AG Since 2026-05-10 | — | Equity (Common) |
1.44%
|
$11.38 | 569,796 |